Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock
Journal of Cardiac Failure · 2024
DOI: 10.1016/j.cardfail.2024.07.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2024. Verfasst von Joshua Longinow und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Kauffman Center for Heart Failure Treatment and Recovery, Cleveland Cl…. Hauptthemen laut MEDLINE: Intra-Aortic Balloon Pumping, Shock, Cardiogenic, Amyloidosis, Hemodynamics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In those with heart failure-related cardiogenic shock (HF-CS), an intra-aortic balloon pump (IABP) may improve hemodynamics and be useful as a bridge to advanced therapies. We explore whether those with cardiac amyloidosis and HF-CS might experience hemodynamic improvement and describe the hemodynamic response after IABP. METHODS AND RESULTS: We retrospectively identified consecutive patients with a diagnosis of cardiac amyloid, either light chain or transthyretin, who were admitted to our intensive care unit with HF-CS. Patients were excluded if an IABP was placed during heart transplant or for shock related to acute myocardial infarction. Invasive hemodynamics before and after IABP placement were assessed. We identified 23 patients with cardiac amyloid who had an IABP placed for HF-CS. The 1-year survival rate was 74% and most (65%) were bridged to heart transplant, although 1 patient was bridged to destination left ventricular assist device. After IABP, the mean arterial pressure, cardiac index, and cardiac power index were significantly increased, whereas mean right atrial pressure, mean pulmonary artery pressure, and pulmonary capillary wedge pressure were all significantly decreased. A smaller left ventricular end-diastolic diameter (per cm) was associated with a higher likelihood of a cardiac index of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Kauffman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio.
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, and the Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
- Centennial Heart, Tristar Centennial Medical Center, Nashville, Tennessee.
- Department of Thoracic and Cardiovascular Surgery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
- Department of Cardiovascular Medicine, Cleveland Clinic Weston Hospital, Weston, Florida.
- Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Kauffman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, Cleveland, Ohio. Electronic address: Leer2@ccf.org.
Zitieren
APA
Longinow, J., Martens, P., Il'giovine, Z. J., Higgins, A., Ives, L., Soltesz, E. G., Tong, M. Z., Estep, J. D., Starling, R. C., Tang, W. H. W., Hanna, M., & Lee, R. (2024). Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.07.019
Vancouver
Longinow J, Martens P, Il'giovine ZJ, Higgins A, Ives L, Soltesz EG, et al. Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock. Journal of Cardiac Failure. 2024. doi:10.1016/j.cardfail.2024.07.019
BibTeX
@article{Longinow2024,
author = {Longinow, Joshua and Martens, Pieter and Il'giovine, Zachary J and Higgins, Andrew and Ives, Lauren and Soltesz, Edward G and Tong, Michael Z and Estep, Jerry D and Starling, Randall C and Tang, W H Wilson and Hanna, Mazen and Lee, Ran},
title = {Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock},
journal = {Journal of Cardiac Failure},
year = {2024},
doi = {10.1016/j.cardfail.2024.07.019}
}
EUVIMED